Blood test may reveal which lymphoma patients will respond to immunotherapy
Cornell engineers and Dana-Farber oncologists found that RNA floating in the plasma carries a signature of a lymphoma tumor's surroundings, one that tracked with whether patients were still in remission a year later.

<p>Cornell engineers and Dana-Farber oncologists found that RNA floating in the plasma carries a signature of a lymphoma tumor's surroundings, one that tracked with whether patients were still in remission a year later.</p>